Related Experiment Video
Updated: Aug 8, 2025

Injections of Lipopolysaccharide into Mice to Mimic Entrance of Microbial-derived Products After Intestinal Barrier Breach
Published on: May 2, 2018
Preliminary Evidence of Differentially Induced Immune Responses by Microparticle-adsorbed LPS in Patients with
1The Department of Medical Microbiology and Immunology, University of California Davis, California, USA.
Abstract:
Inorganic microparticles are ubiquitous in the modern Western diet present as food additives and are actively scavenged by microfold (M) cells overlying human intestinal lymphoid aggregates. In Crohn's disease (CD), inflammation is caused by the inability of the intestinal mucosa to sustain tolerance to gut luminal factors including bacteria and their by-products. Having large, highly charged surface areas dietary particles can avidly bind biomolecules such as lipopolysaccharide (LPS). The aim of this paper was to examine whether the dietary particle, titanium dioxide (TiO2), modified cellular immune responses to LPS differently in peripheral blood mononuclear cells (PBMC) from CD patients compared with healthy controls. Our data showed that LPS-associated particles predominantly stimulated release of IL-1β and induced concurrent cell death in peripheral monocytes following particle uptake in both health and disease. In addition, IL-1β release was increased more in CD patients compared with controls following particle stimulation. In conclusion, LPS adsorption to dietary particulates provides a mechanism for stimulation of phagocytic mononuclear cells and may cause aggravation of mucosal immune responses in inflammatory conditions of the bowel such as CD, irritable bowel syndrome, and autism spectrum disorder and schizophrenia associated gastrointestinal conditions, by immune priming mediated through increased production of pro-inflammatory cytokines.
Insights
Dietary inorganic microparticles like titanium dioxide can bind to lipopolysaccharide (LPS), increasing inflammatory responses. This immune priming effect, particularly IL-1β release, is heightened in Crohn
Area of Science:
- Immunology
- Gastroenterology
- Dietary Science
Background:
- Inorganic microparticles are common food additives.
- Crohn's disease (CD) involves impaired mucosal tolerance to gut factors.
- Dietary particles can bind biomolecules like lipopolysaccharide (LPS).
Purpose of the Study:
- To investigate if titanium dioxide (TiO2) alters immune responses to LPS in peripheral blood mononuclear cells (PBMCs).
- To compare responses between CD patients and healthy controls.
Main Methods:
- Exposure of PBMCs from CD patients and healthy controls to LPS-associated TiO2 particles.
- Measurement of cytokine release (IL-1β) and cell death in monocytes.
Main Results:
- LPS-associated particles stimulated IL-1β release and monocyte cell death in both groups.
- Increased IL-1β release was observed in CD patients compared to controls.
- TiO2 particles enhanced LPS-induced inflammatory responses.
Conclusions:
- LPS adsorption to dietary particles stimulates phagocytic mononuclear cells.
- This mechanism may aggravate inflammatory bowel conditions like CD through immune priming.
- Potential implications for irritable bowel syndrome, autism, and schizophrenia-associated gastrointestinal issues.
Related Concept Videos
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...

